Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis. // Orthopedic Clinics of North America. – URL: https://www.sciencedirect.com/science/article/pii/S003058982600074X?dgcid=rss_sd_all
Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis. Orthopedic Clinics of North America. https://www.sciencedirect.com/science/article/pii/S003058982600074X?dgcid=rss_sd_all
“Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis.” Orthopedic Clinics of North America.
@article{article61111,
title = {Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis},
journal = {Orthopedic Clinics of North America},
url = {https://www.sciencedirect.com/science/article/pii/S003058982600074X?dgcid=rss_sd_all}
}